Edna Mozes
7Patents
3h-index
9Co-inventors
50Inventor score
Filing activity: Dec 10, 1990 → Jan 4, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5556754A | Methods for assessing the ability of a candidate drug to suppress MHC class I expression | Physics | 28 | Expired |
| US5356779A | Assay for direct binding of peptides that are T-cell epitopes to MHC gene products on intact antigen-presenting cells and the use thereof for screening susceptibility of autoimmune diseases | Physics | 7 | Expired |
| US6066621A | Synthetic peptides for the treatment of myasthenia gravis | Human Necessities | 5 | Expired |
| US6613536B1 | Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus | Physics | 3 | Expired |
| US5871950A | Methods of treating autoimmune diseases and transplantation rejection | Physics | 1 | Expired |
| US7858738B2 | Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus | Chemistry; Metallurgy | 0 | Active |
| US11167005B2 | Peptides for treating Sjogren's syndrome | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.